2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement 
MacroGenics Announces Presentations at the 2021 AACR Annual Meeting
ROCKVILLE, MD, April 10, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative...
Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021
MYC genomic amplification found to be a key driver of sensitivity to CDK9 inhibition Pan-cancer anti-tumor activity, including in tumors...
Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR™ T Cell Technology Designed to Overcome Immune Suppression in Solid Tumors at the American Association for Cancer Research (AACR) Virtual 2021 Meeting
Proprietary TurboCAR Technology Platform Allows Cytokine Activation Signaling to be Selectively Engineered into AlloCAR T™ CellsNew TurboCAR Constructs Can Be Induced...
Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting
CAMBRIDGE, Mass. and NEW YORK, April 10, 2021 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology...
Bolt Biotherapeutics Announces AACR 2021 Presentation of Boltbody™ Platform Mechanism of Action and Clinical Properties of Lead ISAC, BDC-1001
Bolt’s first-in-class clinical candidate, BDC-1001, is a novel HER2-targeting, TLR 7/8 immune-stimulating antibody conjugate (ISAC) currently in an ongoing Phase...
Kymera Therapeutics Presents Late-Breaking Preclinical Data Highlighting Superiority of Dual-Targeting Activity of IRAKIMiD Degrader KT-413 at AACR Annual Meeting 2021
KT-413-mediated degradation of IRAK4 and IMiD substrates has synergistic effect on MYD88-NFkB and IRF4-Type 1 Interferon pathways resulting in superior...
Valneva Announces Publication of 2020 Universal Registration Document and Provides Business Updates
Saint-Herblain (France), April 10, 2021 – Valneva SE (“Valneva” or the "Company”), a specialty vaccine company focused on the development...
Valneva Files Registration Statement for Proposed United States Initial Public Offering
Saint-Herblain (France), April 10, 2021 – Valneva SE (the “Company”), a specialty vaccine company focused on the development and commercialization...
National Research Corporation Declares Quarterly Dividend
Lincoln, Nebraska, April 09, 2021 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) announced that its Board of Directors has declared...
Biogen Announces Two New Nominees for Election to Board of Directors
Nominees bring diverse business and public health experience key to Biogen’s mission to pioneer and lead in neuroscienceCompany thanks Director...
Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer
Company Announcement FDA action date is Oct 10, 2021BLA submission supported by positive pivotal innovaTV 204 trial results presented at...
Scilex Holding, a Subsidiary of Sorrento, Has Received From FDA a sNDA Approval for ZTlido® Label Expansion
PALO ALTO, Calif., April 09, 2021 (GLOBE NEWSWIRE) -- Scilex Holding (“Scilex”), an over 99% owned subsidiary of Sorrento Therapeutics...
Convocation annual general meeting and extraordinary general shareholders meeting
Regulated informationNazareth (Belgium)/Rotterdam (Netherlands), 9 April 2021 Convocation annual general meeting and extraordinary general shareholders meeting The board of directors...
Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas
Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas PARIS AND...
Why COVID is just the tip of a terrifying, but potentially revolutionary, antibiotic resistant iceberg
LONDON, April 09, 2021 (GLOBE NEWSWIRE) -- Based in the UK, SpectrumX is currently raising capital to expand its testing...
Fulcrum Therapeutics Presents Published Structure of Investigational Small Molecule FTX-6058 at the American Chemical Society (ACS) Spring 2021 Virtual Conference
Company initiates dosing in Phase 1 healthy volunteer multiple ascending dose (MAD) cohortCAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWIRE) -- Fulcrum...
Genetic Technologies Provides Update on COVID-19 Risk Test Launch
MELBOURNE, Australia, April 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics...
Axiom Presents “Unified Platforms: Key Modules and Data Considerations for Study Success” at Outsourcing in Clinical Trials Israel 2021
TEL AVIV, Israel, April 09, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions...
BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)
Westport, CT, April 09, 2021 (GLOBE NEWSWIRE) -- Global leaders, including Amazon, Bayer, and GE Healthcare, joined the AAIH to...
Merit Medical Systems to Announce First Quarter Results on April 29, 2021
SOUTH JORDAN, Utah, April 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer...